Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF – Get Rating) was the target of a large drop in short interest in the month of December. As of December 30th, there was short interest totalling 1,400 shares, a drop of 26.3% from the December 15th total of 1,900 shares. Based on an average daily trading volume, of 9,000 shares, the days-to-cover ratio is currently 0.2 days.
Algernon Pharmaceuticals Price Performance
Shares of OTCMKTS AGNPF opened at $1.64 on Thursday. Algernon Pharmaceuticals has a 1 year low of $1.52 and a 1 year high of $9.28. The stock's 50-day simple moving average is $1.90 and its 200-day simple moving average is $2.63.
Get
Algernon Pharmaceuticals alerts:
Algernon Pharmaceuticals Company Profile
(Get Rating)
Algernon Pharmaceuticals Inc operates as a clinical stage pharmaceutical development company. It focuses on the areas of non-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, pancreatic and small cell lung cancer, and acute lung injury in Canada, Australia, and New Zealand.
Featured Stories
- Get a free copy of the StockNews.com research report on Algernon Pharmaceuticals (AGNPF)
- Procter & Gamble Earnings: A Gamble Worth Taking
- Stocks Slide, Economic Report Paints Gloomy Picture For Economy
- What does Nu Holdings Stock Have To Do With Warren Buffett?
- J.B. Hunt Gets A Flat, Logistic Companies Come Into Focus
- Is Intel Stock On The Verge Of Breaking Out?
Receive News & Ratings for Algernon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Algernon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
阿爾傑農製藥有限公司(場外交易代碼:AGNPF-GET評級)是空頭股數12月份大幅下跌的目標。截至12月30日,空頭股數共有1,400股,比12月15日的1,900股減少了26.3%。以日均成交量9,000股計算,目前天數與回補比率為0.2天。
Algernon製藥公司的價格表現
週四,OTCMKTS AGNPF的股價開盤報1.64美元。Algernon PharmPharmticals的一年低點為1.52美元,一年高位為9.28美元。該股的50日簡單移動均線切入位為1.90美元,200日簡單移動均線切入位為2.63美元。
到達
阿爾傑農製藥公司警報:
Algernon製藥公司簡介
(獲取評級)
Algernon製藥公司是一家臨床階段藥物開發公司。它集中在加拿大、澳大利亞和紐西蘭的非酒精性脂肪性肝炎、慢性腎臟疾病、炎症性腸道疾病、特發性肺纖維化、慢性咳嗽、胰腺癌和小細胞肺癌以及急性肺損傷等領域。
專題報道
- 免費獲取StockNews.com關於Algernon製藥的研究報告(AGNPF)
- 寶潔收益:一場值得冒險的賭博
- 股市下滑,經濟報告為經濟描繪黯淡圖景
- 如新控股股票與沃倫·巴菲特有什麼關係?
- J.B.亨特買房,物流公司成為焦點
- 英特爾股票是否即將突破?
獲得Algernon PharmPharmticals Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Algernon製藥和相關公司的最新新聞和分析師評級的每日簡要摘要。